Abstract

Acute Pancreatitis (AP) is among the most common hospital gastrointestinal diagnosis; understanding the mechanisms underlying the severity of AP are critical for development of new treatment options for this disease. Here, we evaluate the biological function of phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3) in AP pathogenesis in two independent genetically engineered mouse models of AP. PFKFB3 is elevated in AP and severe AP (SAP) and knockout of Pfkfb3 abrogates the severity of alcoholic SAP (FAEE-SAP). Using a combination of genetic, pharmacological, and molecular studies we define the interaction of PFKFB3 with inositol 1,4,5-trisphosphate receptor (IP3R) as a key event mediating this phenomenon. Further analysis demonstrated that the interaction between PFKFB3 and IP3R promotes FAEE-SAP severity by altering intracellular calcium homeostasis in acinar cells. Together our results support a PFKFB3-driven mechanism controlling AP pathobiology and define this enzyme as a therapeutic target to ameliorate the severity of this dismal condition.

Authors

Tan Zhang, Shengchuan Chen, Liang Li, Yuepeng Jin, Siying Liu, Zhu Liu, Fengyu Shi, Lifen Xie, Panpan Guo, Andrew C. Cannon, Akmal Ergashev, Haiping Yao, Chaohao Huang, Baofu Zhang, Lijun Wu, Hongwei Sun, Siming Chen, Yunfeng Shan, Zhengping Yu, Ezequiel J. Tolosa, Jianghuai Liu, Martin E. Fernandez-Zapico, Feng Ma, Gang Chen

×

Download this citation for these citation managers:

Or, download this citation in these formats:

If you experience problems using these citation formats, send us feedback.

Advertisement